• share
• favorite_border

Salt Lake City, Utah 鈥斅燗rtificial Intelligence (AI) is reshaping the way we comprehend, detect and treat eye conditions, bringing new hope to millions worldwide. During the upcoming week (May 4 - 8) at the 2025 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Salt Lake City, Utah, researchers will share breakthroughs on how AI is influencing the future of eye and vision health research and patient care, from enhancing clinical decision-making to simplifying workflows to equip patients with educational tools to create personalized care plans.

• share
• favorite_border

JMIR Publications invites submissions to a new theme issue titled 鈥淭he Importance of Telerehabilitation and Future Directions for the Field鈥� in its open access journal JMIR Rehabilitation and Assistive Technologies.

• share
• favorite_border

Salt Lake City, Utah 鈥� Glaucoma continues to be聽a public health challenge that affects around 4.22 million Americans and remains the leading cause of irreversible blindness in the U.S. Often called the 鈥渟ilent thief of sight鈥�, glaucoma is a group of eye diseases that damages the optic nerve, the vital link between the eyes and brain.

• share
• favorite_border

Salt Lake City, Utah 鈥� If you or someone聽you know has trouble seeing things far away, you most likely have nearsightedness, also known as myopia. It is a common eye problem which, if not managed, can lead to serious issues like glaucoma, vision loss or blindness. The number of people with myopia is on the rise, with experts predicting that nearly half the world could be myopic by 2050.

• share
• favorite_border

Alon Harris, MS, PhD, FARVO, has been named the 2025 recipient of The Glaucoma Foundation鈥檚 (TGF) Robert Ritch Award for Innovation and Excellence in Glaucoma.

• share
• favorite_border

Transformative research offering fresh insights and treatment advancements for age-related macular degeneration (AMD), the leading cause of blindness in adults over age 50, will be among the highlights showcased from May 4 - 8 at the Association for Research in Vision and Ophthalmology鈥檚 (ARVO) 2025 Annual Meeting in Salt Lake City, Utah.

• share
• favorite_border

From May 4 - 8,聽more than 8,000 scientists will gather at the Association for Research in Vision and Ophthalmology鈥檚 (ARVO) 2025 Annual Meeting in Salt Lake City, Utah, to share the latest discoveries in eye and vision research. Many studies being presented focus on the retina, the light-sensitive tissue at the back of the eye that captures the images people see and sends signals to the brain so that people can see and understand the world around them.

• share
• favorite_border

• share
• favorite_border

In a study published in Ophthalmology, physicians followed 562 patients in the United States and India over a three-month period to identify risk factors that could be easily managed with early intervention.

• share
• favorite_border

Led by UNC School of Medicine鈥檚 Weili Lin, PhD, researchers document cognitive milestones revealed in children from birth to toddlerhood in brain imaging study.

• share
• favorite_border

A groundbreaking open-source computer program uses artificial intelligence to analyze videos of patients with Parkinson's disease and other movement disorders. The tool, called VisionMD, helps doctors more accurately monitor subtle motor changes, improving patient care and advancing clinical research.

• share
• favorite_border

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to their liver. This disease, known as metastatic uveal melanoma, is traditionally very hard to treat and usually has poor outcomes.

• share
• favorite_border

A preclinical model developed at UT Southwestern Medical Center that recapitulates a rare infant-onset form of diabetes suggests the condition stems from gradual damage to the pancreas through misregulation of a molecular pathway called the unfolded protein response (UPR). The findings, published in Molecular Metabolism, could one day lead to new ways to treat more common subsets of diabetes, including Types 1 and 2, which affect hundreds of millions worldwide.

• share
• favorite_border

Dr. Gilbert Bernier, a neuroscientist and professor at the University of Montreal who is pushing the boundaries of regenerative medicine.

• share
• favorite_border

A new study has revealed that Australia鈥檚 public libraries are struggling to adequately support people with print disabilities, leaving a significant portion of the population without access ...

• share
• favorite_border

Extended nails and false eyelashes are putting female basketball players at an even higher risk for eye injuries on the court and possible sight-threatening infections, says the American Academy of Ophthalmology.

• share
• favorite_border

A landmark five-year clinical study has revealed that spectacle lenses equipped with highly aspherical lenslets (HAL) can significantly slow the progression of myopia and axial elongation in children. Compared to an extrapolated control group, HAL lenses reduced myopia progression by 1.75 diopters (D) and axial elongation by 0.72 mm, effectively lowering the risk of developing high myopia (鈭�6.00 D or worse) by fourfold. These findings mark a critical advancement in long-term myopia management, offering a safe and non-invasive intervention amid a growing global vision crisis. With nearly half the world鈥檚 population projected to be myopic by 2050, HAL lenses may hold the key to preventing serious complications such as retinal detachment and glaucoma.